GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » ROA %

No.25 Central Pharmaceutical JSC (HSTC:UPH) ROA % : 0.00% (As of . 20)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. No.25 Central Pharmaceutical JSC's annualized Net Income for the quarter that ended in . 20 was ₫ Mil. No.25 Central Pharmaceutical JSC's average Total Assets over the quarter that ended in . 20 was ₫ 0 Mil. Therefore, No.25 Central Pharmaceutical JSC's annualized ROA % for the quarter that ended in . 20 was Not Available.

The historical rank and industry rank for No.25 Central Pharmaceutical JSC's ROA % or its related term are showing as below:

HSTC:UPH's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.815
* Ranked among companies with meaningful ROA % only.

No.25 Central Pharmaceutical JSC ROA % Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC ROA % Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
ROA %

No.25 Central Pharmaceutical JSC Semi-Annual Data
ROA %

Competitive Comparison of No.25 Central Pharmaceutical JSC's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, No.25 Central Pharmaceutical JSC's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


No.25 Central Pharmaceutical JSC's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, No.25 Central Pharmaceutical JSC's ROA % distribution charts can be found below:

* The bar in red indicates where No.25 Central Pharmaceutical JSC's ROA % falls into.



No.25 Central Pharmaceutical JSC ROA % Calculation

No.25 Central Pharmaceutical JSC's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

No.25 Central Pharmaceutical JSC's annualized ROA % for the quarter that ended in . 20 is calculated as:

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (. 20) net income data. ROA % is displayed in the 30-year financial page.


No.25 Central Pharmaceutical JSC  (HSTC:UPH) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

Note: The Net Income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


No.25 Central Pharmaceutical JSC ROA % Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


No.25 Central Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines